A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
about
Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritisIdentifying and managing factors that interfere with or worsen blood pressure control.Topical diclofenac therapy for osteoarthritis: a meta-analysis of randomized controlled trials.Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial.
P2860
A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A 6-week, multicentre, randomi ...... ib in osteoarthritis patients.
@ast
A 6-week, multicentre, randomi ...... ib in osteoarthritis patients.
@en
type
label
A 6-week, multicentre, randomi ...... ib in osteoarthritis patients.
@ast
A 6-week, multicentre, randomi ...... ib in osteoarthritis patients.
@en
prefLabel
A 6-week, multicentre, randomi ...... ib in osteoarthritis patients.
@ast
A 6-week, multicentre, randomi ...... ib in osteoarthritis patients.
@en
P2093
P2860
P356
P1476
A 6-week, multicentre, randomi ...... ib in osteoarthritis patients.
@en
P2093
Gerhard Krammer
Kirstin Stricker
P2860
P2888
P356
10.1186/1471-2474-9-118
P577
2008-09-08T00:00:00Z
P5875
P6179
1053438541